Jeffrey L. Seeburger

Publications

468

Citations

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Oxford

United States Military Academy

John Radcliffe Hospital

Jeffrey L. Seeburger is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, neurology, and neurodegenerative diseases.

Top concepts

MedicineNeurologyDementiaBiomarkersNeuroscienceNeuropathologyAlzheimer's DiseaseNeurodegenerative DiseasesHealthTreatment

Publications per year

1993–2015

Publications

Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort

Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck et al. · Journal of Alzheimer s Disease · 2015 · 97 citations

Spinal cord motoneurons express p75NGFR and p145trkB mRNA in amyotrophic lateral sclerosis

Jeffrey L. Seeburger, Seth Tarras, Howard M. Natter et al. · Brain Research · 1993 · 90 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Molecular Neuroscience +11

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

Ronald C. Hendrickson, Anita Y. H. Lee, Qinghua Song et al. · PLoS ONE · 2015 · 71 citations · Full text

Human Cerebrospinal Fluid, Neurochemical Biomarkers, Proteomic Technology +17

Elevated Cortical Extracellular Fluid Glutamate in Transgenic Mice Expressing Human Mutant (G93A) Cu/Zn Superoxide Dismutase

Guillermo M. Alexander, Jeffrey S. Deitch, Jeffrey L. Seeburger et al. · Journal of Neurochemistry · 2000 · 57 citations · Full text

Scales as outcome measures for Alzheimer's disease

Ronald S. Black, Barry Greenberg, J. Michael Ryan et al. · Alzheimer s & Dementia · 2009 · 52 citations · Full text

Alzheimer's Disease, Psychiatry, Geriatrics +14

Rows per page

1–5 of 9